VAGELOS P ROY 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Apr 5, 2023
Insider Transaction Report
Form 4
VAGELOS P ROY
Director
Transactions
- Gift
Common Stock
2023-04-03−259→ 125,493 total(indirect: by CLAT)
Holdings
- 1,963(indirect: By 401(k))
Common Stock
- 3,609(indirect: By Trust)
Common Stock
- 312,578
Common Stock
- 23,461(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.